N/A
N=19
Pilot Test of a Chinese Menu Plan for Type 2 Diabetes
Type 2 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02327429 ↗Enrolled (actual)
19
Serious AEs
—
Results posted
Jun 2017
Primary outcome: Primary: Change in Energy Intake (3-day Food Record) — -299 kcal
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- A Chinese menu plan for type 2 diabetes (Behavioral)
- Age
- Adult, Older Adult · 35+ yrs
- Sex
- All
- Sponsor
- University of Alberta
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Energy Intake (3-day Food Record) |
-299 | — |
| PRIMARY Change in Carbohydrate Intake (3-day Food Record) |
0.4 | — |
| PRIMARY Change in Protein Intake (3-day Food Record) |
1.7 | — |
| PRIMARY Change in Total Fat Intake (3-day Food Record) |
0.6 | — |
| PRIMARY Change in Saturated Fat Intake (3-day Food Record) |
0.1 | — |
| PRIMARY Change in Dietary Fibre Intake (3-day Food Record) |
0.8 | — |
| PRIMARY Change in Added Sucrose Intake (3-day Food Record) |
0.2 | — |
| PRIMARY Change in Sodium Intake (3-day Food Record) |
-275 | — |
| PRIMARY Change in Calcium Intake (3-day Food Record) |
124 | — |
| PRIMARY Change in Cholesterol Intake (3-day Food Record) |
11 | — |
| SECONDARY Change in Hemoglobin A1c (A1c) |
-0.13 | — |
| SECONDARY Change in Body Mass Index (BMI) |
-0.4 | — |
| SECONDARY Change in Waist Circumference |
-2.0 | — |
| SECONDARY Change in Fasting Triglyceride |
-1.2 | — |
| SECONDARY Change in Fasting Total Cholesterol |
-21.4 | — |
| SECONDARY Change in Fasting Low-density Lipoprotein Cholesterol |
-18.4 | — |
| SECONDARY Change in Fasting High-density Lipoprotein Cholesterol |
-2.8 | — |
Summary
In Canada, there is a fast-growing population with diabetes, and the majority of diabetes cases are type 2 diabetes (T2D). Diabetes and its complications, such as cardiovascular diseases, eye disease and foot disease, impair the quality of life and life expectancy.
Chinese are the second largest visible minority in Canada. The diabetes incidence increased much more rapidly in the Canadian population of Chinese origin compared with that of European origin in past decades. Cultural factors are very likely to affect individual behaviour in diabetes treatment. Both international and Canadian diabetes organizations have recognized the importance of taking into account the cultural background and individual preferences in diabetes treatment.
However, there lacks cultural relevant nutritional recommendations or guidelines for Chinese Canadians except some literally translated materials which may not be culturally relevant. In order to fill the gap, the investigators have developed a Chinese menu plan that includes commonly consumed Chinese dishes with nutrients breakdown and cooking tips to provide guidance for patients in their daily meal planning. This menu plan is a cultural translation of the Canadian nutritional guidelines, which is urgently needed among Chinese immigrants with T2D in Edmonton, according to our previous needs assessment.
In this pilot test, the investigators will examine the feasibility and effectiveness of the Chinese menu plan. Twenty Chinese with T2D in Edmonton will be recruited to use the menu plan for 3 consecutive months and relevant indices of T2D will be tested as indicators of effectiveness. Feedback from participants will be obtained through one-on-one interviews and appropriate modifications will be made to the menu plan.
Eligibility Criteria
Inclusion Criteria
- ≥ 35 years of age;
- diagnosed with T2D or prediabetes;
- baseline hemoglobin A1C ≥ 6.0%;
- treatment with lifestyle, and/or oral hypoglycemic medications or insulin;
- Chinese origin;
- able to read and write Chinese or English
Exclusion Criteria
- severe gastrointestinal or renal problems that would preclude a diet according to the Nutrition Therapy Guidelines for Diabetes
Data sourced from ClinicalTrials.gov (NCT02327429). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.